Lupin Limited

BSE : 500257 | NSE : LUPIN

Industry : Pharma Drugs | ISIN : INE326A01037 | FreeFloat : 55.00% | FnO : Yes | LotSize : 850


Intellectual Capital (IC)-9,472.88
Net Worth (NW)12,221.98
Intrinsic Worth (IW)2,749.10
Market Cap (MC)33,951.55
Economic Value Added-445.77
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)-344.58%
IC Gross Margin (EBITDA/IC)-14.71%
IC Net Margin (NPT/IC)4.62%
Knowledge Turnover (Sales/IC)-1.68
Market to Intrinsic Value (MC/IW)12.35

As OfIntrinsic ValueMarket Price
31 Mar 2022Rs. 60.49Rs. 747.05
26 May 2022 ---- Rs. 600.50
10.25     1.71%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 643.90AccumulateSell on Rallies
KB > 50% : No50 DMA : Rs. 731.82
0 < M2IV < 1 : NoVol-Price trend : Rising

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-19
C
4418.38
4490.59
933.42
616.33
530.71
303.05
377.60
Sep-19
C
4359.55
4492.92
318.79
-2.68
-89.14
-127.07
-214.23
Dec-19
C
3716.09
3769.27
235.01
-18.22
-106.82
-835.00
-891.98
Mar-20
C
3845.74
4054.34
818.00
603.74
496.36
391.29
-148.95
Jun-20
C
3527.86
3571.14
531.92
317.28
273.02
106.90
183.54
Sep-20
C
3835.00
3859.96
606.56
393.83
360.21
211.02
239.61
Dec-20
C
4017.36
4038.53
800.08
555.76
524.84
438.25
646.59
Mar-21
C
3783.10
3841.32
765.94
550.22
518.38
460.36
410.76
Jun-21
C
4270.19
4298.02
992.72
783.96
750.49
542.46
628.65
Sep-21
C
4091.33
4164.14
-1251.02
-2170.35
-2204.78
-2098.04
-2213.45
Dec-21
C
4160.93
4194.99
403.91
200.48
167.08
545.52
513.43
Mar-22
C
3883.03
3898.71
283.66
-43.53
-85.00
-517.98
-357.31
* C - Consolidated, S - Standalone